Dr. Milch is a 1980 graduate of Harvard Medical School, having completed his undergraduate studies in biology at Stanford University in 1976. Upon finishing his clinical and research responsibilities in 1984, Dr. Milch moved to New York City to pursue a business career. Between 1980 and 1989 Dr. Milch has been a principal of Bermil Industries, a closely held corporation controlled by the Milch Family, involved with capital equipment manufacture and distribution, financing, real estate development, and other entrepreneurial activities. After a portion of Bermil was sold to a public company in 1989, Dr. Milch turned a significant portion of his time and attention to venture investments in technology and the life sciences.

  Dr. Milch and his associates have invested in or advised on a wide variety opportunities including The American Blood Institute (private sale), Intelligent Medical Imaging (IPO), Biofield (IPO), Nitinol (IPO), Datatec Systems (reverse merger), Warp Technologies (reverse merger), MiniMed (acquired by Medtronic), Advanced Bionics (acquired by Boston Scientific), Theravance (IPO), and others. Recently his activity has focused on medical device companies from Israel.